We are N,N-Dimethyl-N-octyl-1-octanaminium bromide CAS:3026-69-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name:N,N-Dimethyl-N-octyl-1-octanaminium bromide
CAS.NO:3026-69-5
Synonyms:N,N-Dimethyl-N-octyl-1-octanaminium bromide
N,N-di-n-octyl-N,N-dimethyl ammonium bromide
N,N-dimethyl-N,N-dioctylammonium bromide
Dimethyldioctylammonium Bromide
Physical and Chemical Properties:
Melting Point 220-222°C
Molecular Formula C11H26BrN
Molecular Weight 252.235
Exact Mass 251.124847
LogP 0.05710
Specification:
Appearance:White powder
Assay:99%/80%
Packing:25 kg/drum or 180 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Phase-transfer catalyst in chemical reactions.
Our quaternary ammonium salt series products reach more than 200 kinds, and the product categories cover high-content quaternary ammonium salt (powder, crystal, paste), low-content quaternary ammonium salt (liquid, paste), special quaternary ammonium salt, and quaternary ammonium salt. Alkali, etc., and can provide customized services for related products.
Our main R&D directions are: oilfield chemicals and quaternary ammonium salt downstream products (such as emulsifiers for pesticides, disinfectants for aquatic products, surfactants with special requirements for daily chemicals, etc.) and new innovative structures Surfactant. Therefore, in addition to supplying conventional surfactant products, we can also customize various surfactant products with special requirements according to customer needs to meet the special needs of various industries for surfactants.
Market News:Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. 1,5-dihydro-pyrimido[5,4-d]pyrimidinetetrathione manufacturer.Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. 3-(4-(3-chloro-4-(hydroxymethyl)phenyl)piperazin-1-yl)-1-(4-(methylsulfonyl)phenyl)propan-1-one supplier.The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. (1’S,2R)-tert-butyl 2-[1-hydroxy-1-(2-naphthyl)methyl]benzothiazolidine-3-carboxylate producer.
